Dapsona (diaminodifenil-sulfona) en Dermatología. Conocimiento actual de un fármaco antiguo.
The administration of diaminodiphenyl sulfone (commonly known as dapsone) has been controversial and evidence lacking in the literature. Mainly due to its adverse effects, interactions and idiosyncratic adverse effects (agranulocytosis or hypersensitivity syndrome) are frequent, prescription is not...
| Published in: | Dermatología Revista Mexicana Vol. 64; no. 3; pp. 294 - 309 |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Published: |
Edicion y Farmacia S.A. de C.V.
May2020
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=lth&AN=143622868&site=ehost-live header: @attributes: shortDbName: lth uiTerm: 143622868 longDbName: MedicLatina uiTag: AN controlInfo: bkinfo: jinfo: jid: 01854038 ZZT jtl: Dermatología Revista Mexicana issn: 01854038 maglogo: N pubinfo: dt: May2020 vid: 64 iid: 3 pid: 20199 pub: Edicion y Farmacia S.A. de C.V. artinfo: ui: 143622868 ppf: 294 ppct: 15 formats: fmt: @attributes: type: P size: 1.5MB tig: atl: Dapsona (diaminodifenil-sulfona) en Dermatología. Conocimiento actual de un fármaco antiguo. aug: au: de Aguinaga-Inurriaga, Alejandro Eduardo Melgarejo-Gómez, Aralí Tirado-Sánchez, Andrés Bonifaz, Alexandro affil: Servicio de Dermatología, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, México. Servicio de Dermatología, Hospital General de México Dr. Eduardo Liceaga, Ciudad de México. sug: keyword: Dapsone Diaminodiphenyl sulfone dapsona Dapsone Diaminodifenil-sulfona Diaminodiphenyl sulfone ab: The administration of diaminodiphenyl sulfone (commonly known as dapsone) has been controversial and evidence lacking in the literature. Mainly due to its adverse effects, interactions and idiosyncratic adverse effects (agranulocytosis or hypersensitivity syndrome) are frequent, prescription is not common nowadays. However, when talking about dermatological diseases (inflammatory, neutrophilic, eosinophilic and other types), it is technically first line pharmacological resource. As a matter of fact, evidence-based medicine and consequential information may be helpful in clinician’s hands in order to be effectively used and applied for the sake of patient’s wellness. La administración de diaminodifenil-sulfona (comúnmente conocida como dapsona) ha sido controvertida y en la bibliografía se carece de evidencia pertinente. Principalmente debido a que los eventos adversos (agranulocitosis o síndrome de hipersensibilidad) son relativamente frecuentes y graves, la prescripción no es común en la actualidad. Sin embargo, cuando se habla de enfermedades dermatológicas (inflamatorias, neutrofílicas, eosinofílicas, entre otras), es un recurso farmacológico de primera línea. De hecho, la medicina basada en la evidencia y la información consecuente pueden ser útiles en las manos de los médicos y dermatólogos para que se utilicen y apliquen eficazmente por el bienestar del paciente. pubtype: Academic Journal doctype: Article src: R language: Spanish refInfo: copyright: @attributes: flag: Y custom: Copyright of Dermatología Revista Mexicana is the property of Edicion y Farmacia S.A. de C.V. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. item: Dermatología Revista Mexicana holder: Edicion y Farmacia S.A. de C.V. dt: @attributes: year: 2020 holdings: @attributes: islocal: N |
|---|